首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content
【2h】

A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content

机译:PPARα介导的脂毒性在糖尿病性心肌病发病机理中的关键作用:膳食脂肪含量的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To explore the role of peroxisome proliferator-activated receptor α (PPARα)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARα deficiency (PPARα−/−) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARα−/− mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARα gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.
机译:探讨过氧化物酶体增殖物激活受体α(PPARα)介导的失调在心肌代谢,糖尿病性心肌病,PPARα缺乏症(PPARα-/-)或心脏受限的过表达的发病机理中的作用[肌球蛋白重链(MHC)-PPAR]进行了表征。尽管保护PPARα-/-小鼠免于糖尿病引起的心脏肥大的发展,但糖尿病和MHC-PPAR基因型的组合导致的心肌病表型比单独的一种严重。糖尿病MHC-PPAR小鼠的心肌病伴有心肌长链甘油三酸酯积聚。饲喂富含长链脂肪酸甘油三酸酯的饮食的MHC-PPAR小鼠会加剧心肌病的表型,这种作用可以通过停止高脂饮食而得到逆转,而在富含中链甘油三酯饮食的小鼠中则不存在。活性氧中间体被确定为MHC-PPAR小鼠心肌病作用的候选介质。这些结果将PPARα基因调节途径的失调与糖尿病患者的心脏功能障碍联系在一起,并为治疗糖尿病性心肌病的血清降脂策略提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号